Market Research Logo

BioVentrix Inc - Product Pipeline Analysis, 2017 Update

Summary

BioVentrix Inc (BioVentrix) is a medical device company that develops congestive heart failure treatment solutions. The company provides revivent myocardial anchoring systems that restore the size, volume and resulting function of the left ventricle for improving cardiac function in heart failure patients. It also provides less invasive ventricular enhancement therapy that offers a novel procedure used to improve the left ventricle efficiency in CHF patients by excluding the scarred, non-functioning portion of the left ventricle. The company’s services comprise hospital consulting services that include heart failure management crisis and heart failure management solutions. BioVentrix is headquartered in San Ramon, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and Recent Developments
  • The report analyzes all pipeline products in development for the company BioVentrix Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


BioVentrix Inc Company Overview 4
BioVentrix Inc Company Snapshot 4
BioVentrix Inc Pipeline Products and Ongoing Clinical Trials Overview 4
BioVentrix Inc – Pipeline Analysis Overview 7
BioVentrix Inc - Key Facts 7
BioVentrix Inc - Major Products and Services 8
BioVentrix Inc Pipeline Products by Development Stage 9
BioVentrix Inc Ongoing Clinical Trials by Trial Status 11
BioVentrix Inc Pipeline Products Overview 13
Next Generation Revivent-TC System 13
Next Generation Revivent-TC System Product Overview 13
PliCath HF 14
PliCath HF Product Overview 14
PliCath HF Clinical Trial 15
Revivent-TC System 16
Revivent-TC System Product Overview 16
Revivent-TC System Clinical Trial 17
BioVentrix Inc - Key Competitors 18
BioVentrix Inc - Key Employees 19
BioVentrix Inc - Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
BioVentrix Inc, Recent Developments 21
May 22, 2017: BioVentrix announces the 1st Revivent TC TransCatheter Ventricular Enhancement procedure for Ischemic Cardiomyopathy treatment at Deutsches Herzzentrum Berlin in Germany English 21
Apr 17, 2017: BioVentrix announces the 1st image fusion-guided Revivent TC TransCatheter Ventricular Enhancement procedure for treating Ischemic Cardiomyopathy 21
Feb 06, 2017: BioVentrix Announces NUB Reimbursement Status 1 for Revivent TC TransCatheter Ventricular Enhancement System in Germany English 22
Dec 19, 2016: BioVentrix announces the 1st Revivent TC TransCatheter Ventricular Enhancement procedure in Germany after receiving CE-Mark Certification 22
Dec 19, 2016: BioVentrix announces the 1st Revivent TC TransCatheter Ventricular Enhancement procedure in Germany after receiving CE-Mark Certification 23
Nov 21, 2016: BioVentrix announces the 1st Revivent TC TransCatheter Ventricular Enhancement procedure for Ischemic Cardiomyopathy treatment in the Netherlands 23
Oct 04, 2016: Steven Healy appointed as Chairman of the Board of Directors of BioVentrix 24
Jun 27, 2016: BioVentrix Receives CE Marking Certification for Revivent TC, the First Minimally Invasive Heart Failure Treatment to Restore the Left Ventricle 24
May 31, 2016: BioVentrix receives FDA IDE Approval for its Pivotal Clinical Trial, ALIVE 25
May 16, 2016: BioVentrix Announces Successful First-In-Man, Catheter-Based Endovascular Clinical Procedure with Revivent-TC System for Heart Failure Treatment 26
Appendix 27
Methodology 27
About GlobalData 29
Contact Us 29
Disclaimer 29
List of Tables
BioVentrix Inc Pipeline Products and Ongoing Clinical Trials Overview 4
BioVentrix Inc Pipeline Products by Equipment Type 5
BioVentrix Inc Pipeline Products by Indication 6
BioVentrix Inc Ongoing Clinical Trials by Trial Status 6
BioVentrix Inc, Key Facts 7
BioVentrix Inc, Major Products and Services 8
BioVentrix Inc Number of Pipeline Products by Development Stage 9
BioVentrix Inc Pipeline Products Summary by Development Stage 10
BioVentrix Inc Ongoing Clinical Trials by Trial Status 11
BioVentrix Inc Ongoing Clinical Trials Summary 12
Next Generation Revivent-TC System - Product Status 13
Next Generation Revivent-TC System - Product Description 13
PliCath HF - Product Status 14
PliCath HF - Product Description 14
PliCath HF - Phase II Study of the BioVentrix PliCath HF System for the Treatment of Ischemic Cardiomyopathy 15
Revivent-TC System - Product Status 16
Revivent-TC System - Product Description 16
Revivent-TC System - Clinical Study of the BioVentrix Revivent TC for the Treatment of Ischemic Cardiomyopathy 17
Revivent-TC System - Clinical Study of the BioVentrix Revivent TC System for Treatment of Left Ventricular Aneurysms 17
BioVentrix Inc, Key Employees 19
Glossary 28
List of Figuress
BioVentrix Inc Pipeline Products by Equipment Type
BioVentrix Inc Pipeline Products by Development Stage
BioVentrix Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report